Personalis, Inc. (PSNL)
15.60
-0.33
(-2.07%)
USD |
NASDAQ |
Oct 16, 14:11
Personalis SG&A Expense (TTM) : 67.03M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.03M |
| March 31, 2026 | 59.21M |
| December 31, 2025 | 53.57M |
| September 30, 2025 | 50.64M |
| June 30, 2025 | 49.05M |
| March 31, 2025 | 46.85M |
| December 31, 2024 | 46.19M |
| September 30, 2024 | 46.54M |
| June 30, 2024 | 47.07M |
| March 31, 2024 | 47.23M |
| December 31, 2023 | 49.73M |
| September 30, 2023 | 56.03M |
| June 30, 2023 | 58.84M |
| March 31, 2023 | 62.58M |
| December 31, 2022 | 63.97M |
| September 30, 2022 | 59.85M |
| June 30, 2022 | 57.21M |
| Date | Value |
|---|---|
| March 31, 2022 | 52.76M |
| December 31, 2021 | 47.70M |
| September 30, 2021 | 44.91M |
| June 30, 2021 | 40.56M |
| March 31, 2021 | 36.84M |
| December 31, 2020 | 33.69M |
| September 30, 2020 | 29.16M |
| June 30, 2020 | 27.42M |
| March 31, 2020 | 25.18M |
| December 31, 2019 | 22.08M |
| September 30, 2019 | 15.69M |
| June 30, 2019 | 12.29M |
| March 31, 2019 | 9.432M |
| December 31, 2018 | 7.575M |
| September 30, 2018 | 7.575M |
| June 30, 2018 | 4.917M |
| March 31, 2018 | 2.313M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tempus AI, Inc. | 834.84M |
| 10X Genomics, Inc. | 297.01M |
| Alamar Biosciences, Inc. (California) | 31.22M |
| Adaptive Biotechnologies Corp. | 180.38M |
| Champions Oncology, Inc. | 21.81M |